Hitachi Chemical Advanced Therapeutics Solutions (HCATS), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. Regenerative Medicine are now operating under the joint name

minaris-regenerative-medicine-logo

The company remains a wholly owned subsidiary of Hitachi Chemical Co., Ltd., which has announced its name change to Showa Denko Materials on October 1, 2020.

We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products. 

Creating Future Cell Therapy Miracles Together

Derived from the Japanese word “mirai” meaning future, and the English word “miracle”, meaning “an extraordinary event”, our new name speaks to our goal to exceed the expectations of our customers.

Learn More About Us

For over 20 years, we have served more than 180 clients with outstanding quality and reliability.

Development

Our manufacturing development services help you design efficient and robust manufacturing processes for your cell and gene therapy.

Learn More

GMP Manufacturing

We offer a comprehensive manufacturing experience that is fully compliant with the relevant regional regulatory requirements of our global facilities.

Learn More

Our Global Locations

Mountain View, CA Allendale, NJ Munich, Germany Ottobrunn, Germany Yokohama, Japan

Stay up to date on the latest news.
© 2020 Minaris Regenerative Medicine  |   Privacy Policy  |   Imprint